430 related articles for article (PubMed ID: 30576764)
1. Evaluating the role of orexins in the pathophysiology and treatment of depression: A comprehensive review.
Shariq AS; Rosenblat JD; Alageel A; Mansur RB; Rong C; Ho RC; Ragguett RM; Pan Z; Brietzke E; McIntyre RS
Prog Neuropsychopharmacol Biol Psychiatry; 2019 Jun; 92():1-7. PubMed ID: 30576764
[TBL] [Abstract][Full Text] [Related]
2. Orexin Receptor Antagonists in the Treatment of Depression: A Leading Article Summarising Pre-clinical and Clinical Studies.
Fagan H; Jones E; Baldwin DS
CNS Drugs; 2023 Jan; 37(1):1-12. PubMed ID: 36436175
[TBL] [Abstract][Full Text] [Related]
3. Chronopathophysiological implications of orexin in sleep disturbances and lifestyle-related disorders.
Tsuneki H; Wada T; Sasaoka T
Pharmacol Ther; 2018 Jun; 186():25-44. PubMed ID: 29289556
[TBL] [Abstract][Full Text] [Related]
4. Orexin Receptor Antagonists as Emerging Treatments for Psychiatric Disorders.
Han Y; Yuan K; Zheng Y; Lu L
Neurosci Bull; 2020 Apr; 36(4):432-448. PubMed ID: 31782044
[TBL] [Abstract][Full Text] [Related]
5. Orexin Receptor Antagonists: New Therapeutic Agents for the Treatment of Insomnia.
Roecker AJ; Cox CD; Coleman PJ
J Med Chem; 2016 Jan; 59(2):504-30. PubMed ID: 26317591
[TBL] [Abstract][Full Text] [Related]
6. Orexin receptor antagonists in the pathophysiology and treatment of sleep disorders and epilepsy.
Sheibani M; Shayan M; Khalilzadeh M; Ghasemi M; Dehpour AR
Neuropeptides; 2023 Jun; 99():102335. PubMed ID: 37003137
[TBL] [Abstract][Full Text] [Related]
7. Emerging role of orexin antagonists in insomnia therapeutics: An update on SORAs and DORAs.
Kumar A; Chanana P; Choudhary S
Pharmacol Rep; 2016 Apr; 68(2):231-42. PubMed ID: 26922522
[TBL] [Abstract][Full Text] [Related]
8. Hypocretin/Orexin Receptor Pharmacology and Sleep Phases.
Sun Y; Tisdale RK; Kilduff TS
Front Neurol Neurosci; 2021; 45():22-37. PubMed ID: 34052813
[TBL] [Abstract][Full Text] [Related]
9. Orexin OX
Jacobson LH; Chen S; Mir S; Hoyer D
Curr Top Behav Neurosci; 2017; 33():105-136. PubMed ID: 27909987
[TBL] [Abstract][Full Text] [Related]
10. Orexin Receptor Antagonism: Normalizing Sleep Architecture in Old Age and Disease.
Kron JOJ; Keenan RJ; Hoyer D; Jacobson LH
Annu Rev Pharmacol Toxicol; 2024 Jan; 64():359-386. PubMed ID: 37708433
[TBL] [Abstract][Full Text] [Related]
11. Orexin Receptor Antagonists and Insomnia.
Wu X; Xue T; Chen Z; Wang Z; Chen G
Curr Psychiatry Rep; 2022 Oct; 24(10):509-521. PubMed ID: 35972717
[TBL] [Abstract][Full Text] [Related]
12. Orexin Receptor Antagonism Improves Sleep and Reduces Seizures in Kcna1-null Mice.
Roundtree HM; Simeone TA; Johnson C; Matthews SA; Samson KK; Simeone KA
Sleep; 2016 Feb; 39(2):357-68. PubMed ID: 26446112
[TBL] [Abstract][Full Text] [Related]
13. Orexin in sleep, addiction and more: is the perfect insomnia drug at hand?
Hoyer D; Jacobson LH
Neuropeptides; 2013 Dec; 47(6):477-88. PubMed ID: 24215799
[TBL] [Abstract][Full Text] [Related]
14. The role of orexin in Alzheimer disease: From sleep-wake disturbance to therapeutic target.
Gao F; Liu T; Tuo M; Chi S
Neurosci Lett; 2021 Nov; 765():136247. PubMed ID: 34530113
[TBL] [Abstract][Full Text] [Related]
15. Current models of insomnia disorder: a theoretical review on the potential role of the orexinergic pathway with implications for insomnia treatment.
Palagini L; Geoffroy PA; Balestrieri M; Miniati M; Biggio G; Liguori C; Menicucci D; Ferini-Strambi L; Nobili L; Riemann D; Gemignani A
J Sleep Res; 2023 Aug; 32(4):e13825. PubMed ID: 36786121
[TBL] [Abstract][Full Text] [Related]
16. Hypocretin/orexin antagonism enhances sleep-related adenosine and GABA neurotransmission in rat basal forebrain.
Vazquez-DeRose J; Schwartz MD; Nguyen AT; Warrier DR; Gulati S; Mathew TK; Neylan TC; Kilduff TS
Brain Struct Funct; 2016 Mar; 221(2):923-40. PubMed ID: 25431268
[TBL] [Abstract][Full Text] [Related]
17. Discovery and development of orexin receptor antagonists as therapeutics for insomnia.
Winrow CJ; Renger JJ
Br J Pharmacol; 2014 Jan; 171(2):283-93. PubMed ID: 23731216
[TBL] [Abstract][Full Text] [Related]
18. The Insomnia-Addiction Positive Feedback Loop: Role of the Orexin System.
Fragale JE; James MH; Avila JA; Spaeth AM; Aurora RN; Langleben D; Aston-Jones G
Front Neurol Neurosci; 2021; 45():117-127. PubMed ID: 34052815
[TBL] [Abstract][Full Text] [Related]
19. Promotion of Wakefulness and Energy Expenditure by Orexin-A in the Ventrolateral Preoptic Area.
Mavanji V; Perez-Leighton CE; Kotz CM; Billington CJ; Parthasarathy S; Sinton CM; Teske JA
Sleep; 2015 Sep; 38(9):1361-70. PubMed ID: 25845696
[TBL] [Abstract][Full Text] [Related]
20. Recent trends in orexin research--2010 to 2015.
Boss C; Roch C
Bioorg Med Chem Lett; 2015 Aug; 25(15):2875-87. PubMed ID: 26045032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
